RINEXIN

Main information

  • Trade name:
  • RINEXIN 50 mg prolonged-release tablet
  • Dosage:
  • 50 mg
  • Pharmaceutical form:
  • prolonged-release tablet
  • Prescription type:
  • Prescription only
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • RINEXIN 50 mg prolonged-release tablet
    Finland
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Phenylpropanolamine
  • Product summary:
  • Previous_names: RINEXIN LEO

Status

  • Source:
  • Fimea
  • Authorization status:
  • Marketing authorization granted
  • Authorization number:
  • 7517
  • Authorization date:
  • 30-01-2008
  • Last update:
  • 26-07-2018